Percutaneous heart valves for the Nouvelle-Aquitaine regional purchasing group

Summary

The procurement comprises 23 lots for percutaneous heart valves and other medical devices used in cardiac interventions. Products include aortic valve bioprostheses with delivery and loading systems, mitral and tricuspid valve devices, catheters, guidewires, cerebral protection systems and temporary pacing electrodes. Supplies will be provided to hospitals in the Nouvelle-Aquitaine regional purchasing group under a framework agreement with orders. The total estimated value is EUR 79,325,982; prices are unit prices and payment is based on quantities supplied. The agreement is planned to start on 1 April 2027 and run for 24 months, with one possible 12-month extension, giving a maximum term of 36 months. Lots 6 and 13 may have up to two suppliers, provided there are enough suitable bidders and tenders; the other lots may have one framework supplier. Product descriptions and quantities vary by lot. Tenders must be submitted electronically by 12:00 on 29 October 2026. Award criteria are technical merit (55%), price (40%) and sustainable development (5%).